Discover Aitken Klee LPP Blog

On May 18, 2012, Amgen Canada Inc. and Amgen Inc. (“Amgen”) commenced a proceeding (Court File No. T-989-12) under the Patented Medicines (Notice of Compliance)...

Ramipril section 8 damages – distinct “but for” worlds for each generic

29 May 2012

Marcus Klee

PM NOC, Section 8

The Federal Court recently decided several cases dealing with section 8 of the Patented Medicines (Notice of Compliance) Regulations (the “Regulations”). The first decision (2012 FC...

Court denies all summary judgment motions in Genentech & U Penn HERCEPTIN suit

21 May 2012

Marcus Klee

biologics, Foreign decisions, Foreign Litigation

On May 14, 2012 the United States District Court for the Northern District of California dismissed a number of competing summary judgment motions in respect...

Supreme Court of Canada denies leave to hear section 8 cases

17 May 2012

Marcus Klee

Canadian decisions, PM NOC, Section 8

On May 17, 2012, the Supreme Court of Canada announced its decisions not to hear appeals in three section 8 cases: Apotex Inc. v. Nycomed...

BONIVA dosing regimen patent held obvious in summary judgment motion

14 May 2012

Marcus Klee

Foreign decisions, Foreign Litigation

On May 7, 2012, the United States District Court for the District of New Jersey granted a summary judgment motion holding that claims 1 to...

PRECEDEX: enantiomer patent valid and enforceable; method of use patent obvious

10 May 2012

Marcus Klee

Foreign decisions, Foreign Litigation

On May 4, 2012, the District Court of New Jersey issued an amended memorandum opinion in relation to Sandoz’ paragraph IV challenge to U.S. Patents...